关注
Vlad Taru
Vlad Taru
Medical University of Vienna, Vienna, Austria
在 lirec.ro 的电子邮件经过验证
标题
引用次数
引用次数
年份
Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
V Taru, G Szabo, W Mehal, T Reiberger
Journal of Hepatology, 2024
152024
How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A …
MG Taru, L Neamti, V Taru, LM Procopciuc, B Procopet, M Lupsor-Platon
Diagnostics 13 (4), 788, 2023
152023
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
R Paternostro, WJ Kwanten, BS Hofer, G Semmler, A Bagdadi, I Luzko, ...
Journal of hepatology 81 (5), 827-836, 2024
82024
Validation and performance of Chronic Liver Disease Questionnaire (CLDQ-RO) in the Romanian population
V Taru, MG Indre, MD Ignat, A Forgione, T Racs, BA Olar, O Farcau, ...
J Gastrointestin Liver Dis 30 (2), 240-246, 2021
52021
Non-dental oral cavity findings in gastroesophageal reflux disease: a systematic review and meta-analysis
MG Indre, D Sampelean, V Taru, A Cozma, D Sampelean, MV Milaciu, ...
Journal of Mind and Medical Sciences 8 (1), 60-70, 2021
42021
FAST and Agile–the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin
MG Taru, C Tefas, L Neamti, I Minciuna, V Taru, A Maniu, I Rusu, ...
Plos one 19 (5), e0303971, 2024
32024
Recently validated non-invasive tests for liver fibrosis assessment have great performance in identifying NASH patients at risk for decompensation
V Taru, MG Taru, B Petrushev, R Ioana, H Stefanescu, A Fodor, MD Ignat, ...
Journal of Hepatology 78, S295-S296, 2023
12023
Natural history of patients with NAFLD-associated compensated advanced chronic liver disease stratified according to severity of portal hypertension
R Paternostro, WJ Kwanten, BS Hofer, G Semmler, A Bagdadi, I Luzko, ...
Zeitschrift für Gastroenterologie 61 (05), P31, 2023
12023
Reply to:" Pyroptosis in liver failure: A twisted firestarter"
V Taru, T Reiberger
Journal of hepatology 82 (2), e93-e94, 2025
2025
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis
BS Hofer, B Simbrunner, P Königshofer, K Brusilovskaya, O Petrenko, ...
Digestive and Liver Disease 57 (2), 450-458, 2025
2025
Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis
BS Hofer, B Simbrunner, P Königshofer, K Brusilovskaya, O Petrenko, ...
United European Gastroenterology Journal, 2024
2024
WED-332 FASTand Agile-the MASLD Drift: validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven MASLD patients of prevalent caucasian origin
MG Taru, C Tefas, L Neamti, I Minciuna, V Taru, A Maniu, I Rusu, ...
Journal of Hepatology 80, S555-S556, 2024
2024
THU-540 Characterization of in vivo mouse models of regressive fibrosis and resolving portal hypertension
K Bonitz, P Königshofer, B Hofer, O Petrenko, T Sorz, V Taru, ...
Journal of Hepatology 80, S267, 2024
2024
WED-122-YI The soluble guanylate cyclase pathway is dysregulated in rodent models of cirrhosis and portal hypertension
T Sorz-Nechay, K Brusilovskaya, P Konigshofer, B Hofer, O Petrenko, ...
Journal of Hepatology 80, S197, 2024
2024
WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regression
T Sorz-Nechay, K Brusilovskaya, P Königshofer, B Hofer, O Petrenko, ...
Journal of Hepatology 80, S198, 2024
2024
WED-089-YI Characterising the hemodynamic and pro-inflammatory profile of a CCl4/LPS-induced acute-on-chronic liver failure (ACLF) rat model
V Taru, T Sorz-Nechay, B Hofer, O Petrenko, P Königshofer, K Bonitz, ...
Journal of Hepatology 80, S186, 2024
2024
THU-071 Impact of underlying portal hypertension and systemic inflammation on acute-on-chronic liver failure (ACLF) severity and outcome
V Taru, G Kramer, L Balcar, B Hofer, M Schwarz, N Dominik, L Hartl, ...
Journal of Hepatology 80, S165, 2024
2024
Auswirkungen von portaler Hypertension und systemischer Entzündung auf Schweregrad und Prognose des akut-auf-chronischen Leberversagens (ACLF)
G Kramer, V Taru, L Balcar, BS Hofer, M Schwarz, N Dominik, L Hartl, ...
Zeitschrift für Gastroenterologie 62 (05), P59, 2024
2024
An Interdisciplinary Approach to Alcohol Use Disorders: What Hepatologists Can Do in a Resource-Limited Setting
A Fodor, A Nicoara, M Taru, V Taru, A Bumbu, H Stefanescu
Alcohol and Alcohol-related Diseases, 1429-1439, 2023
2023
DECIPHERING OF THE HEPATIC SINGLE-CELL INTERACTOME IN PRIMARY SCLEROSING CHOLANGITIS
O Petrenko, C Mangana, T Sorz, BS Hofer, B Simbrunner, K Zinober, ...
The Liver Meeting 2023, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20